Skip to main content
Top
Published in: BMC Cancer 1/2023

Open Access 01-12-2023 | Human Papillomavirus | Research

Developing a predictive nomogram for colposcopists: a retrospective, multicenter study of cervical precancer identification in China

Authors: Peng Xue, Samuel Seery, Sumeng Wang, Yu Jiang, Youlin Qiao

Published in: BMC Cancer | Issue 1/2023

Login to get access

Abstract

Background

Colposcopic examination with biopsy is the standard procedure for referrals with abnormal cervical cancer screening results; however, the decision to biopsy is controvertible. Having a predictive model may help to improve high-grade squamous intraepithelial lesion or worse (HSIL+) predictions which could reduce unnecessary testing and protecting women from unnecessary harm.

Methods

This retrospective multicenter study involved 5,854 patients identified through colposcopy databases. Cases were randomly assigned to a training set for development or to an internal validation set for performance assessment and comparability testing. Least Absolute Shrinkage and Selection Operator (LASSO) regression was used to reduce the number of candidate predictors and select statistically significant factors. Multivariable logistic regression was then used to establish a predictive model which generates risk scores for developing HSIL+. The predictive model is presented as a nomogram and was assessed for discriminability, and with calibration and decision curves. The model was externally validated with 472 consecutive patients and compared to 422 other patients from two additional hospitals.

Results

The final predictive model included age, cytology results, human papillomavirus status, transformation zone types, colposcopic impressions, and size of lesion area. The model had good overall discrimination when predicting HSIL + risk, which was internally validated (Area Under the Curve [AUC] of 0.92 (95%CI 0.90–0.94)). External validation found an AUC of 0.91 (95%CI 0.88–0.94) across the consecutive sample, and 0.88 (95%CI 0.84–0.93) across the comparative sample. Calibration suggested good coherence between predicted and observed probabilities. Decision curve analysis also suggested this model would be clinically useful.

Conclusion

We developed and validated a nomogram which incorporates multiple clinically relevant variables to better identify HSIL + cases during colposcopic examination. This model may help clinicians determining next steps and in particular, around the need to refer patients for colposcopy-guided biopsies.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.CrossRefPubMed Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.CrossRefPubMed
2.
go back to reference Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008–2030): a population-based study. Lancet Oncol. 2012;13(8):790–801.CrossRefPubMed Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008–2030): a population-based study. Lancet Oncol. 2012;13(8):790–801.CrossRefPubMed
3.
go back to reference Xue P, Ng MTA, Qiao Y. The challenges of colposcopy for cervical cancer screening in LMICs and solutions by artificial intelligence. BMC Med. 2020;18(1):169.CrossRefPubMedPubMedCentral Xue P, Ng MTA, Qiao Y. The challenges of colposcopy for cervical cancer screening in LMICs and solutions by artificial intelligence. BMC Med. 2020;18(1):169.CrossRefPubMedPubMedCentral
4.
go back to reference Zhang J, Zhao Y, Dai Y, Dang L, Ma L, Yang C, Li Y, Kong L, Wei L, Zhang S, et al. Effectiveness of high-risk human papillomavirus testing for Cervical Cancer Screening in China: a Multicenter, Open-label, Randomized Clinical Trial. JAMA Oncol. 2021;7(2):263–70.CrossRefPubMed Zhang J, Zhao Y, Dai Y, Dang L, Ma L, Yang C, Li Y, Kong L, Wei L, Zhang S, et al. Effectiveness of high-risk human papillomavirus testing for Cervical Cancer Screening in China: a Multicenter, Open-label, Randomized Clinical Trial. JAMA Oncol. 2021;7(2):263–70.CrossRefPubMed
5.
go back to reference Xue P, Gao LL, Yin J, Han LL, Zhao J, Li L, Seery S, Han XY, Li TY, Jiang Y, et al. A direct comparison of four high-risk human papillomavirus tests versus the cobas test: detecting CIN2 + in low-resource settings. J Med Virol. 2019;91(7):1342–50.CrossRefPubMed Xue P, Gao LL, Yin J, Han LL, Zhao J, Li L, Seery S, Han XY, Li TY, Jiang Y, et al. A direct comparison of four high-risk human papillomavirus tests versus the cobas test: detecting CIN2 + in low-resource settings. J Med Virol. 2019;91(7):1342–50.CrossRefPubMed
6.
go back to reference Leeson SC, Alibegashvili T, Arbyn M, Bergeron C, Carriero C, Mergui JL, Nieminen P, Prendiville W, Redman CW, Rieck GC, et al. The future role for colposcopy in Europe. J Low Genit Tract Dis. 2014;18(1):70–8.CrossRefPubMed Leeson SC, Alibegashvili T, Arbyn M, Bergeron C, Carriero C, Mergui JL, Nieminen P, Prendiville W, Redman CW, Rieck GC, et al. The future role for colposcopy in Europe. J Low Genit Tract Dis. 2014;18(1):70–8.CrossRefPubMed
7.
go back to reference Lukic A, De Vincenzo R, Ciavattini A, Ricci C, Senatori R, Ruscito I, Frega A. Are We Facing a New Colposcopic Practice in the HPV Vaccination Era? Opportunities, Challenges, and New Perspectives. Vaccines (Basel)2021, 9(10). Lukic A, De Vincenzo R, Ciavattini A, Ricci C, Senatori R, Ruscito I, Frega A. Are We Facing a New Colposcopic Practice in the HPV Vaccination Era? Opportunities, Challenges, and New Perspectives. Vaccines (Basel)2021, 9(10).
8.
go back to reference Wentzensen N, Schiffman M, Silver MI, Khan MJ, Perkins RB, Smith KM, Gage JC, Gold MA, Conageski C, Einstein MH, et al. ASCCP Colposcopy Standards: risk-based Colposcopy Practice. J Low Genit Tract Dis. 2017;21(4):230–4.CrossRefPubMed Wentzensen N, Schiffman M, Silver MI, Khan MJ, Perkins RB, Smith KM, Gage JC, Gold MA, Conageski C, Einstein MH, et al. ASCCP Colposcopy Standards: risk-based Colposcopy Practice. J Low Genit Tract Dis. 2017;21(4):230–4.CrossRefPubMed
9.
go back to reference Wentzensen N, Massad LS, Mayeaux EJ Jr, Khan MJ, Waxman AG, Einstein MH, Conageski C, Schiffman MH, Gold MA, Apgar BS, et al. Evidence-based Consensus Recommendations for Colposcopy Practice for Cervical Cancer Prevention in the United States. J Low Genit Tract Dis. 2017;21(4):216–22.CrossRefPubMed Wentzensen N, Massad LS, Mayeaux EJ Jr, Khan MJ, Waxman AG, Einstein MH, Conageski C, Schiffman MH, Gold MA, Apgar BS, et al. Evidence-based Consensus Recommendations for Colposcopy Practice for Cervical Cancer Prevention in the United States. J Low Genit Tract Dis. 2017;21(4):216–22.CrossRefPubMed
10.
go back to reference Khan MJ, Werner CL, Darragh TM, Guido RS, Mathews C, Moscicki AB, Mitchell MM, Schiffman M, Wentzensen N, Massad LS, et al. ASCCP Colposcopy Standards: role of Colposcopy, benefits, potential Harms, and terminology for colposcopic practice. J Low Genit Tract Dis. 2017;21(4):223–9.CrossRefPubMed Khan MJ, Werner CL, Darragh TM, Guido RS, Mathews C, Moscicki AB, Mitchell MM, Schiffman M, Wentzensen N, Massad LS, et al. ASCCP Colposcopy Standards: role of Colposcopy, benefits, potential Harms, and terminology for colposcopic practice. J Low Genit Tract Dis. 2017;21(4):223–9.CrossRefPubMed
11.
go back to reference Schiffman M, Wentzensen N. Issues in optimising and standardising the accuracy and utility of the colposcopic examination in the HPV era. Ecancermedicalscience. 2015;9:530.CrossRefPubMedPubMedCentral Schiffman M, Wentzensen N. Issues in optimising and standardising the accuracy and utility of the colposcopic examination in the HPV era. Ecancermedicalscience. 2015;9:530.CrossRefPubMedPubMedCentral
12.
go back to reference Silver MI, Andrews J, Cooper CK, Gage JC, Gold MA, Khan MJ, Massad LS, Parvu V, Perkins RB, Schiffman M, et al. Risk of cervical intraepithelial neoplasia 2 or worse by Cytology, Human Papillomavirus 16/18, and Colposcopy Impression: a systematic review and Meta-analysis. Obstet Gynecol. 2018;132(3):725–35.CrossRefPubMedPubMedCentral Silver MI, Andrews J, Cooper CK, Gage JC, Gold MA, Khan MJ, Massad LS, Parvu V, Perkins RB, Schiffman M, et al. Risk of cervical intraepithelial neoplasia 2 or worse by Cytology, Human Papillomavirus 16/18, and Colposcopy Impression: a systematic review and Meta-analysis. Obstet Gynecol. 2018;132(3):725–35.CrossRefPubMedPubMedCentral
13.
go back to reference Ren H, Jia M, Zhao S, Li H, Fan S. Factors correlated with the Accuracy of Colposcopy-Directed Biopsy: a systematic review and Meta-analysis. J Invest Surg. 2022;35(2):284–92.CrossRefPubMed Ren H, Jia M, Zhao S, Li H, Fan S. Factors correlated with the Accuracy of Colposcopy-Directed Biopsy: a systematic review and Meta-analysis. J Invest Surg. 2022;35(2):284–92.CrossRefPubMed
14.
go back to reference Bornstein J, Bentley J, Bösze P, Girardi F, Haefner H, Menton M, Perrotta M, Prendiville W, Russell P, Sideri M, et al. 2011 colposcopic terminology of the International Federation for Cervical Pathology and Colposcopy. Obstet Gynecol. 2012;120(1):166–72.CrossRefPubMed Bornstein J, Bentley J, Bösze P, Girardi F, Haefner H, Menton M, Perrotta M, Prendiville W, Russell P, Sideri M, et al. 2011 colposcopic terminology of the International Federation for Cervical Pathology and Colposcopy. Obstet Gynecol. 2012;120(1):166–72.CrossRefPubMed
15.
go back to reference Waxman AG, Chelmow D, Darragh TM, Lawson H, Moscicki AB. Revised terminology for cervical histopathology and its implications for management of high-grade squamous intraepithelial lesions of the cervix. Obstet Gynecol. 2012;120(6):1465–71.CrossRefPubMedPubMedCentral Waxman AG, Chelmow D, Darragh TM, Lawson H, Moscicki AB. Revised terminology for cervical histopathology and its implications for management of high-grade squamous intraepithelial lesions of the cervix. Obstet Gynecol. 2012;120(6):1465–71.CrossRefPubMedPubMedCentral
16.
go back to reference Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, Huh WK, Kim JJ, Moscicki AB, Nayar R, et al. : 2019 ASCCP risk-based Management Consensus Guidelines for abnormal cervical Cancer screening tests and Cancer Precursors. J Low Genit Tract Dis. 2020;24(2):102–31.CrossRefPubMedPubMedCentral Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, Huh WK, Kim JJ, Moscicki AB, Nayar R, et al. : 2019 ASCCP risk-based Management Consensus Guidelines for abnormal cervical Cancer screening tests and Cancer Precursors. J Low Genit Tract Dis. 2020;24(2):102–31.CrossRefPubMedPubMedCentral
17.
go back to reference Carreon JD, Sherman ME, Guillén D, Solomon D, Herrero R, Jerónimo J, Wacholder S, Rodríguez AC, Morales J, Hutchinson M, et al. CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples. Int J Gynecol Pathol. 2007;26(4):441–6.CrossRefPubMed Carreon JD, Sherman ME, Guillén D, Solomon D, Herrero R, Jerónimo J, Wacholder S, Rodríguez AC, Morales J, Hutchinson M, et al. CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples. Int J Gynecol Pathol. 2007;26(4):441–6.CrossRefPubMed
18.
go back to reference Moons KG, Altman DG, Reitsma JB, Ioannidis JP, Macaskill P, Steyerberg EW, Vickers AJ, Ransohoff DF, Collins GS. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015;162(1):W1–73.CrossRefPubMed Moons KG, Altman DG, Reitsma JB, Ioannidis JP, Macaskill P, Steyerberg EW, Vickers AJ, Ransohoff DF, Collins GS. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015;162(1):W1–73.CrossRefPubMed
19.
20.
go back to reference CLOPPER CJ, PEARSON ES: THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIAL. Biometrika. 1934;26(4):404–13.CrossRef CLOPPER CJ, PEARSON ES: THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIAL. Biometrika. 1934;26(4):404–13.CrossRef
21.
go back to reference Wentzensen N, Walker JL, Gold MA, Smith KM, Zuna RE, Mathews C, Dunn ST, Zhang R, Moxley K, Bishop E, et al. Multiple biopsies and detection of cervical cancer precursors at colposcopy. J Clin Oncol. 2015;33(1):83–9.CrossRefPubMed Wentzensen N, Walker JL, Gold MA, Smith KM, Zuna RE, Mathews C, Dunn ST, Zhang R, Moxley K, Bishop E, et al. Multiple biopsies and detection of cervical cancer precursors at colposcopy. J Clin Oncol. 2015;33(1):83–9.CrossRefPubMed
22.
go back to reference Bai A, Wang J, Li Q, Seery S, Xue P, Jiang Y. Assessing colposcopic accuracy for high-grade squamous intraepithelial lesion detection: a retrospective, cohort study. BMC Womens Health. 2022;22(1):9.CrossRefPubMedPubMedCentral Bai A, Wang J, Li Q, Seery S, Xue P, Jiang Y. Assessing colposcopic accuracy for high-grade squamous intraepithelial lesion detection: a retrospective, cohort study. BMC Womens Health. 2022;22(1):9.CrossRefPubMedPubMedCentral
23.
go back to reference Wentzensen N, Walker J, Smith K, Gold MA, Zuna R, Massad LS, Liu A, Silver MI, Dunn ST, Schiffman M. A prospective study of risk-based colposcopy demonstrates improved detection of cervical precancers. Am J Obstet Gynecol 2018, 218(6):604.e601-604.e608. Wentzensen N, Walker J, Smith K, Gold MA, Zuna R, Massad LS, Liu A, Silver MI, Dunn ST, Schiffman M. A prospective study of risk-based colposcopy demonstrates improved detection of cervical precancers. Am J Obstet Gynecol 2018, 218(6):604.e601-604.e608.
24.
go back to reference Wu Z, Li T, Han Y, Jiang M, Yu Y, Xu H, Yu L, Cui J, Liu B, Chen F, et al. Development of models for cervical cancer screening: construction in a cross-sectional population and validation in two screening cohorts in China. BMC Med. 2021;19(1):197.CrossRefPubMedPubMedCentral Wu Z, Li T, Han Y, Jiang M, Yu Y, Xu H, Yu L, Cui J, Liu B, Chen F, et al. Development of models for cervical cancer screening: construction in a cross-sectional population and validation in two screening cohorts in China. BMC Med. 2021;19(1):197.CrossRefPubMedPubMedCentral
25.
go back to reference Karakitsos P, Chrelias C, Pouliakis A, Koliopoulos G, Spathis A, Kyrgiou M, Meristoudis C, Chranioti A, Kottaridi C, Valasoulis G, et al. Identification of women for referral to colposcopy by neural networks: a preliminary study based on LBC and molecular biomarkers. J Biomed Biotechnol. 2012;2012:303192.CrossRefPubMedPubMedCentral Karakitsos P, Chrelias C, Pouliakis A, Koliopoulos G, Spathis A, Kyrgiou M, Meristoudis C, Chranioti A, Kottaridi C, Valasoulis G, et al. Identification of women for referral to colposcopy by neural networks: a preliminary study based on LBC and molecular biomarkers. J Biomed Biotechnol. 2012;2012:303192.CrossRefPubMedPubMedCentral
26.
go back to reference Kahng J, Kim EH, Kim HG, Lee W. Development of a cervical cancer progress prediction tool for human papillomavirus-positive Koreans: a support vector machine-based approach. J Int Med Res. 2015;43(4):518–25.CrossRefPubMed Kahng J, Kim EH, Kim HG, Lee W. Development of a cervical cancer progress prediction tool for human papillomavirus-positive Koreans: a support vector machine-based approach. J Int Med Res. 2015;43(4):518–25.CrossRefPubMed
27.
go back to reference Branca M, Ciotti M, Giorgi C, Santini D, Di Bonito L, Costa S, Benedetto A, Bonifacio D, Di Bonito P, Paba P, et al. Predicting high-risk human papillomavirus infection, progression of cervical intraepithelial neoplasia, and prognosis of cervical cancer with a panel of 13 biomarkers tested in multivariate modeling. Int J Gynecol Pathol. 2008;27(2):265–73.PubMed Branca M, Ciotti M, Giorgi C, Santini D, Di Bonito L, Costa S, Benedetto A, Bonifacio D, Di Bonito P, Paba P, et al. Predicting high-risk human papillomavirus infection, progression of cervical intraepithelial neoplasia, and prognosis of cervical cancer with a panel of 13 biomarkers tested in multivariate modeling. Int J Gynecol Pathol. 2008;27(2):265–73.PubMed
28.
go back to reference Li Y, Luo H, Zhang X, Chang J, Zhao Y, Li J, Li D, Wang W. Development and validation of a clinical prediction model for endocervical curettage decision-making in cervical lesions. BMC Cancer. 2021;21(1):804.CrossRefPubMedPubMedCentral Li Y, Luo H, Zhang X, Chang J, Zhao Y, Li J, Li D, Wang W. Development and validation of a clinical prediction model for endocervical curettage decision-making in cervical lesions. BMC Cancer. 2021;21(1):804.CrossRefPubMedPubMedCentral
29.
go back to reference Del Pino M, Angeles MA, Martí C, Henere C, Munmany M, Marimon L, Saco A, Rakislova N, Ordi J, Torné A. Colposcopic Impression Has a Key Role in the Estimation of the Risk of HSIL/CIN3. Cancers (Basel)2021, 13(6). Del Pino M, Angeles MA, Martí C, Henere C, Munmany M, Marimon L, Saco A, Rakislova N, Ordi J, Torné A. Colposcopic Impression Has a Key Role in the Estimation of the Risk of HSIL/CIN3. Cancers (Basel)2021, 13(6).
30.
go back to reference WHO Director-. General calls for all countries to take action to help end the suffering caused by cervical cancer WHO Director-. General calls for all countries to take action to help end the suffering caused by cervical cancer
31.
go back to reference Stoler MH, Wright TC Jr, Parvu V, Yanson K, Cooper CK, Andrews J. Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥ 25 years of age, with NILM cytology. Gynecol Oncol. 2019;153(1):26–33.CrossRefPubMed Stoler MH, Wright TC Jr, Parvu V, Yanson K, Cooper CK, Andrews J. Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥ 25 years of age, with NILM cytology. Gynecol Oncol. 2019;153(1):26–33.CrossRefPubMed
32.
go back to reference Xue P, Seery S, Li Q, Jiang Y, Qiao Y. Risk-Based Colposcopy for Cervical Precancer Detection: A Cross-Sectional Multicenter Study in China. Diagnostics (Basel, Switzerland) 2022, 12(11). Xue P, Seery S, Li Q, Jiang Y, Qiao Y. Risk-Based Colposcopy for Cervical Precancer Detection: A Cross-Sectional Multicenter Study in China. Diagnostics (Basel, Switzerland) 2022, 12(11).
33.
go back to reference Xue P, Wang J, Qin D, Yan H, Qu Y, Seery S, Jiang Y, Qiao Y. Deep learning in image-based breast and cervical cancer detection: a systematic review and meta-analysis. NPJ Digit Med. 2022;5(1):19.CrossRefPubMedPubMedCentral Xue P, Wang J, Qin D, Yan H, Qu Y, Seery S, Jiang Y, Qiao Y. Deep learning in image-based breast and cervical cancer detection: a systematic review and meta-analysis. NPJ Digit Med. 2022;5(1):19.CrossRefPubMedPubMedCentral
34.
go back to reference Li Y, Chen J, Xue P, Tang C, Chang J, Chu C, Ma K, Li Q, Zheng Y, Qiao Y. Computer-aided cervical Cancer diagnosis using time-lapsed colposcopic images. IEEE Trans Med Imaging. 2020;39(11):3403–15.CrossRefPubMed Li Y, Chen J, Xue P, Tang C, Chang J, Chu C, Ma K, Li Q, Zheng Y, Qiao Y. Computer-aided cervical Cancer diagnosis using time-lapsed colposcopic images. IEEE Trans Med Imaging. 2020;39(11):3403–15.CrossRefPubMed
35.
go back to reference Li Y, Liu ZH, Xue P, Chen J, Ma K, Qian T, Zheng Y, Qiao YL. GRAND: a large-scale dataset and benchmark for cervical intraepithelial neoplasia grading with fine-grained lesion description. Med Image Anal. 2021;70:102006.CrossRefPubMed Li Y, Liu ZH, Xue P, Chen J, Ma K, Qian T, Zheng Y, Qiao YL. GRAND: a large-scale dataset and benchmark for cervical intraepithelial neoplasia grading with fine-grained lesion description. Med Image Anal. 2021;70:102006.CrossRefPubMed
36.
go back to reference Xue P, Tang C, Li Q, Li Y, Shen Y, Zhao Y, Chen J, Wu J, Li L, Wang W, et al. Development and validation of an artificial intelligence system for grading colposcopic impressions and guiding biopsies. BMC Med. 2020;18(1):406.CrossRefPubMedPubMedCentral Xue P, Tang C, Li Q, Li Y, Shen Y, Zhao Y, Chen J, Wu J, Li L, Wang W, et al. Development and validation of an artificial intelligence system for grading colposcopic impressions and guiding biopsies. BMC Med. 2020;18(1):406.CrossRefPubMedPubMedCentral
37.
go back to reference Mendez MJG, Xue P, Qiao Y. Cervical cancer elimination in the era of COVID-19: the potential role of Artificial Intelligence (AI)-guided digital colposcope cloud platform. EJGO. 2022;43(1):160–2.CrossRef Mendez MJG, Xue P, Qiao Y. Cervical cancer elimination in the era of COVID-19: the potential role of Artificial Intelligence (AI)-guided digital colposcope cloud platform. EJGO. 2022;43(1):160–2.CrossRef
Metadata
Title
Developing a predictive nomogram for colposcopists: a retrospective, multicenter study of cervical precancer identification in China
Authors
Peng Xue
Samuel Seery
Sumeng Wang
Yu Jiang
Youlin Qiao
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2023
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-023-10646-3

Other articles of this Issue 1/2023

BMC Cancer 1/2023 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine